Fusion Startup Equity: Is Federal Funding Worth It?
Fusion startups are accepting federal awards tied to equity. See what the Helion and CFS deals mean for dilution, investors, and the next funding round ahead.
Fusion Startups Are Trading Equity for Federal Awards. Is It Worth It?
A federal award used to be pretty straightforward for a startup: you get funding, you meet the programme requirements, and - at least in theory - you don't have to hand over ownership. That assumption is getting shaky. Helion and Commonwealth Fusion Systems (CFS) have received a combined $260 million from the U.S. Department of Commerce, with non-voting government equity attached to the awards.
The numbers are meaningful, but they're small compared with what each company has raised or committed. The real question is what the deal signals. If the government wants an ownership stake alongside public funding, startups and investors have to fold that into future financing decisions. And if this is the government betting that fusion is a strategic industry, that backing could help companies pay for the expensive development work that comes long before commercial scale.
This isn't just a "free money vs. dilution" choice. The terms matter, as do the company's cash needs, the effect on future rounds, and what "federal backing" actually buys. Here's a way to think about the new bargain, what's known about the Helion and CFS awards, and what other deep-tech founders should ask before accepting similar funding.
Why the federal awards matter to fusion
The Department of Commerce awarded Helion $175 million and CFS $85 million under the CHIPS and Science Act. The money is meant to support advanced semiconductors used to help power and control their fusion reactors. In return, both companies agreed to give the government non-voting shares.
On their own, the awards are modest relative to each company's overall capital needs. CFS has raised about $4 billion, and Helion is close behind with roughly $3.2 billion in committed capital. Fusion development is expensive and slow-moving: specialist materials, complicated manufacturing, and lots of modelling have to happen well before a commercial plant can produce electricity. In other words, a few hundred million dollars doesn't erase the need for substantial follow-on investment.
What makes these awards notable is the policy signal. After years when federal fusion support was either limited or arrived late, the U.S. government is now putting large sums into the sector again. There's also a difference in where the money is coming from: Commerce, not the research-heavy Department of Energy programmes the industry has been pushing for. That distinction matters because it suggests this is targeted support for industrial capabilities - not a broad commitment to fund every stage of fusion development.
The Fusion Industry Association has argued for a larger federal push: a one-time $10 billion investment, including $5.4 billion for startups. Their argument is that the U.S. needs research infrastructure and commercial support to compete with state-backed fusion efforts elsewhere, including China. The Helion and CFS awards are well below that ask. Still, they do show that the government is willing to attach ownership terms to at least some big awards.
Why a small award can still set a precedent
Startup financing gets built up over time. Even if a government equity deal is small in the context of total funding, it can still shape expectations for later programmes - or change how private investors think about the company. The question isn't just how much capital arrives today. It's what terms start to look "normal" for the next award.
There's also a practical difference between money that funds a clearly defined technical milestone and money that supports operations more generally. When the funding is tightly tied to a specific deliverable, it's easier to judge what you're buying. But if the company would have paid for the work anyway, the equity cost deserves extra scrutiny.
The signal cuts both ways
Government support can reassure suppliers, partners, and investors that fusion is being treated as a priority. It can also create new uncertainty. Investors may want to understand how government shares affect later financing, and founders may worry that future public support will come with more ownership terms - or new conditions.
So no, these awards aren't proof that fusion is "solved" commercially. They are a sign that public funding is becoming a more consequential part of the sector's capital stack - and that the rules attached to it are changing.
What government equity changes for a startup
Many grants and a lot of government contracts are described as non-dilutive. The company receives funding without issuing shares that reduce existing owners' percentage stakes. That's why they're attractive to founders and venture investors: the company gets resources, while the government usually doesn't share directly in the upside of a successful commercial outcome.
Equity changes that setup. Now the government becomes a shareholder, even if those shares are non-voting. The government participates in potential upside, and the startup gives up a slice of ownership. Non-voting means it won't get ordinary voting control through those shares, but that label doesn't answer every question about the shares' economic or legal rights. Those details live in the actual financing documents.
The public rationale is simple enough: taxpayers put in capital to support research and domestic industry, and they may benefit if the company succeeds. Helion's chief executive, David Kirtley, said the structure aligns the company and the taxpayer around commercial success. CFS has made a similar point, describing the stake as a way for taxpayers to participate in the upside of research investment.
What is known about the Helion and CFS stakes
Helion said the government's equity is tied to its Series G round, which valued the company at $15.5 billion. The $175 million award implies roughly a 1% stake on that basis. CFS says its government stake is also non-voting and based on its most recent valuation, but it hasn't disclosed that valuation. As a result, the size of the CFS stake isn't publicly known.
That gap matters. The headline award amount alone doesn't let you compare the deals in any real way. To understand the true cost, you'd need details like the share class, the valuation basis, the economic rights, how the stake is treated in future rounds, and any other conditions attached to the award. Public reporting can show the broad shape of the arrangement, but it doesn't spell out every term.
Equity is not the only possible cost
Even when an award doesn't involve shares, it can still come with reporting requirements, compliance obligations, limits on how funds can be used, and milestone conditions. Those aren't automatically deal-breakers - they're part of the price of getting the money. The extra question here is how ownership interacts with those obligations and with the company's existing investors.
Founders shouldn't treat "non-voting" as the same thing as "no impact." A stake can have no direct say in board decisions and still influence ownership calculations, future financing conversations, or the eventual distribution of proceeds. On the other hand, a small, clearly defined stake may be a fair trade if it accelerates a project that otherwise would drag. In practice, the documents - not the label - decide the real trade-off.
How founders and investors should assess the trade-off
For investors, government equity creates questions that ordinary grants typically don't. The government becomes a new shareholder, and the ownership percentages held by existing investors change. Dilution might be limited, but investors will still want to understand what rights are attached to the government's shares and how those shares behave during a future financing round or a sale.
The biggest issue isn't whether the government gets a board vote. It's whether the deal changes the economics or flexibility of later rounds. For example, investors may need clarity on how the government's stake is treated if the company raises at a lower valuation, restructures its share classes, or enters a transaction that distributes proceeds across shareholders. Based on the publicly available information, it's not clear how the Helion and CFS agreements handle every scenario like that, so founders shouldn't assume the answer from the headline.
Government equity can also affect how private capital views the company. Some investors may see it as a helpful signal - strategic support plus capital for work that can be hard to finance otherwise. Others may focus on the complexity and worry that future public awards will create additional dilution. The outcome depends on the investor, the deal terms, and whether the government money actually increases the odds of hitting a valuable technical milestone.
Compare the deal with the realistic alternative
Don't compare this to "equity versus free money." Compare it to the best realistic alternative at that moment in the company's development. If the alternative is a private round with bigger dilution, a delayed timeline, or a smaller scope, the public award may be worth it. If the company can raise similar capital on cleaner terms without hurting execution, then giving up equity is harder to justify.
This comparison has to include timing. If a team is racing toward a technical milestone, getting funding now may matter more than preserving a slightly higher ownership percentage for some later, uncertain moment. If the award arrives too late - or funds work that doesn't actually move the critical path - the equity won't "buy" meaningful acceleration.
Look beyond the headline valuation
A quoted valuation can make the stake look straightforward to calculate, but it's only part of the story. Founders should review how the valuation is applied, what securities are issued, whether any rights differ from what existing investors hold, and how future dilution gets handled. Investors should also check whether accepting the award changes any existing agreements or creates new obligations that could complicate fundraising later.
A practical discipline is to model at least three outcomes: the company succeeds and raises more capital, it needs a down round or restructuring, and it fails to commercialise. Government equity plays differently across those scenarios. The goal isn't to predict the future precisely - it's to test whether the deal stays workable across plausible paths.
A practical framework for deciding whether to accept
Founders can make this decision clearer by breaking the award into four questions: what it funds, what ownership it costs, what conditions it creates, and what it changes about future financing. That way, a big headline number doesn't dominate the whole conversation.
-
Map the money to a specific bottleneck
Figure out what the award will pay for and whether it helps the company get past a real constraint. In fusion, that could include components or semiconductor capabilities used to power and control a reactor. Ask whether the funded work is on the critical path, whether it's additional to the current plan, and what milestone it unlocks. If the award just replaces spending the company was already planning, the strategic value may be smaller than it looks.
-
Calculate the full ownership cost
Don't stop at the advertised percentage. Verify the valuation basis, the share class, the voting status, the economic rights, and how the terms work in future financing rounds. Model dilution alongside existing investor rights and any fundraising plans. If any key term is unclear, treat it as an open due diligence item - not something you assume away.
-
Review operational and financing constraints
Understand how the company has to use the money, what reporting and milestone requirements apply, and what happens if timelines slip. Then check whether the agreement affects other public contracts, private financing documents, or commercial plans. A project can be technically worthwhile and still create operational friction if obligations don't match how the company actually operates.
-
Compare the cost with the best alternative
Put the award side by side with realistic options: raising privately, pursuing a different public programme, changing the schedule, or reducing scope. Include both the financial cost of dilution and the value of faster progress. Don't reject government equity automatically, but don't accept it just because the capital is there.
Key takeaways: Government equity may be worth accepting when it funds a critical project, arrives at useful scale, and has clear terms. It's less compelling when the work is peripheral, the agreement constrains future financing, or the company has a better source of capital. Evaluate the terms and the alternative together.
This also matters if this starts to become a pattern. Thea Energy, Avalanche Energy, Pacific Fusion, and Inertia Enterprises have all received federal awards, contracts, or other forms of federal support without giving the government equity, according to statements they made to TechCrunch. That's a reminder that equity isn't an automatic condition of every public engagement. Founders should assess the specific programme and agreement, not assume every public dollar comes with the same bargain.
The same goes internationally. Germany-based Proxima Fusion has said the German government and the European Union sit on its cap table, including via government-backed investment funds. Public investment can take different forms across jurisdictions. The comparison worth making isn't "which government is investing," but what rights, obligations, and strategic benefits come with each arrangement.
Conclusion
The Helion and CFS deals make federal funding more complicated - but not automatically better or worse. Government equity can be a reasonable trade when it finances important work, arrives at the right time, and comes with terms the company can handle across future rounds. It can also create avoidable cap-table and financing headaches when the award doesn't actually move the business forward.
For founders and investors, the test is straightforward: figure out what the money unlocks, calculate the full cost of the shares, and compare the agreement against the best realistic alternative. The headline amount is only the start. What matters is the deal terms - and the work they enable.